Daiichi Sankyo Co., Ltd.

Form 483 issued December 22, 2023 · Iwaki, Japan

Inspection
Dec 18 – Dec 22, 2023
Investigator
Jolanna A. Norton
Observations
2
Pages
3
FEI number
3002808054

In short: On December 22, 2023, FDA issued a Form 483 with 2 observations to Daiichi Sankyo Co., Ltd. in Iwaki, Fukushima (FEI 3002808054) after an inspection that ran Dec 18 – Dec 22, 2023. The investigator was Jolanna A. Norton. Most observations concern quality system and production; the most-cited regulation is 21 CFR 211.192 (production record review).

At a glance

Quality system and production account for 2 of 2 observations.

Quality system1
Production1

Most cited: 21 CFR 211.192 (1×) · 211.100(a) (1×)

What FDA observed

Preview: the opening words of each observation
  1. 01

    There is a failure to thoroughly review any unexplained discrepancy and the failure of a batch…

  2. 02

    Your firm failed to establish adequate written procedures for production and process controls designed to assure…

The full 483

Plus the full detail behind each one, exactly as FDA wrote it.

Get the full 483

This inspection in context

Questions about this 483

What did FDA find at Daiichi Sankyo Co., Ltd.?

FDA listed 2 observations on this Form 483, mostly about quality system and production. The most-cited regulation is 21 CFR 211.192 (production record review). The opening words of each observation are shown on this page.

Who inspected Daiichi Sankyo Co., Ltd.?

Jolanna A. Norton is named on this Form 483, for the inspection of Dec 18 – Dec 22, 2023. Each investigator has a profile showing what they cite most.

When was Daiichi Sankyo Co., Ltd. inspected by FDA?

The inspection ran Dec 18 – Dec 22, 2023, and the Form 483 is dated December 22, 2023.

How do I get the full Form 483 for Daiichi Sankyo Co., Ltd.?

Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.

$99Get it free